Arch Venture Management, LLC Beam Therapeutics Inc. Transaction History
Arch Venture Management, LLC
- $159 Million
- Q4 2024
A detailed history of Arch Venture Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Arch Venture Management, LLC holds 4,540,132 shares of BEAM stock, worth $138 Million. This represents 70.85% of its overall portfolio holdings.
Number of Shares
4,540,132
Previous 4,834,653
6.09%
Holding current value
$138 Million
Previous $118 Million
4.94%
% of portfolio
70.85%
Previous 71.21%
Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
252Shares Held
78.6MCall Options Held
304KPut Options Held
142K-
Farallon Capital Management LLC San Francisco, CA8.24MShares$251 Million1.09% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$232 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.62MShares$232 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$215 Million1.53% of portfolio
-
Nikko Asset Management Americas, Inc.3.96MShares$120 Million1.1% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $2.14B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...